Clinical trial
Assesslebt of Recombinant HAT-RDT Specificity
NCT05637632 is registered in ClinicalTrials.gov with Institute of Tropical Medicine, Belgium as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assesslebt of Recombinant HAT-RDT Specificity
- Lead sponsor
- Institute of Tropical Medicine, Belgium
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 20, 2022
- Completion date
- February 20, 2023
- Enrollment
- 1,504 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
human african trypanosomiasis